Shares of Chemed Corporation (CHE) took a significant hit on Tuesday, plummeting by 5.71% as the company reported its third-quarter financial results for the period ended September 30, 2024. The stock's decline came in response to the company's weaker-than-expected earnings and revenue figures.
Chemed reported adjusted earnings per share (EPS) of $5.64 for the quarter, missing analysts' consensus estimate of $5.76. The company's revenue rose 7.4% year-over-year to $606.18 million, but it fell short of Wall Street's expectations of $612.22 million.
Despite the earnings miss, Chemed reported a quarterly net income of $75.78 million. However, investors appeared to be disappointed with the company's performance, as evidenced by the stock's sharp decline following the earnings release.
Comments